Colombel JF, Schreiber S, D'Haens G, Rizzo J, et al. Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies. J Crohns Colitis 2023 Dec 9:jjad206. doi: 10.1093.
PMID: 38069472